SCHEMBL20359332

SCHEMBL20359332

COc1ccc(Cn2nc(N3CC[C@@H](N(C)C(=O)O)C3)c3c(Cl)ccnc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE1B Q01064 3/20 0.40
▸ HRH1 P35367 2/20 0.39
▸ KCNH2 Q12809 2/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ CFTR P13569 1/20 0.38
▸ CNR2 P34972 4/20 0.38
▸ UBE2M P61081 1/20 0.37
▸ DCUN1D1 Q96GG9 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ CCR5 P51681 1/20 0.37
▸ CYP2D6 P10635 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ MCHR1 Q99705 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CHRM2 P08172 1/20 0.35
▸ CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20359337 1.00 PDE1B (0.40) PDE1BHRH1KCNH2CHRM1CFTR
SCHEMBL20365227 0.90 AAK1 (0.43) PDE1BHRH1KCNH2CHRM1CFTR
SCHEMBL20358961 0.84 CNR2 (0.48) CNR2PTGDR2MCHR1KDM4EALDH1A1
SCHEMBL20359070 0.84 CNR2 (0.48) CNR2PTGDR2MCHR1KDM4EALDH1A1
SCHEMBL20365247 0.83 CNR2 (0.46) CNR2KDM4EALDH1A1
SCHEMBL20360020 0.82 CNR2 (0.40) HRH1CNR2MCHR1KDM4EALDH1A1
SCHEMBL20360022 0.82 CNR2 (0.40) HRH1CNR2MCHR1KDM4EALDH1A1
SCHEMBL20359466 0.82 CNR2 (0.56) CNR2KDM4EALDH1A1
SCHEMBL20359467 0.82 CNR2 (0.56) CNR2KDM4EALDH1A1
SCHEMBL20359968 0.82 CNR2 (0.40) CHRM1CNR2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194762-A1 PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194762-A1 PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, SYK, LCK PDE1B 409/4885HRH1 2200/4885KCNH2 2193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback